Balaji Amines Limited · NSE:BALAMINES
Balaji Amines — Q2 FY27 Earnings Presentation
39 slides from Balaji Amines's earnings presentation, Nov 4, 2026
Slide 1: Exchange filing cover letter for Q2 FY27 investor presentation
04th November, 2026 To, The General Manager-Department of The Manager-Listing Department, Corporate Services, National Stock Exchange of India Limited, BSE Limited, "Exchange Plaza", 5th Floor, Plot No.C/1, Phiroze Jeejeebhoy Towers, G Block, Bandra-Kurla Complex, Dalal Street, Mumbai - 400 001. Ban
Slide 2: INDIA FIRST. Investor Presentation Q2 & H1 FY27
INDIA FIRST. Building What India Needs Before India Asks for It. BALAJI AMINES LIMITED Investor Presentation | Q2 & H1 FY27
Slide 3: Disclaimer
Disclaimer This presentation and the accompanying slides (the “Presentation”), which have been prepared by Balaji Amines Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securiti
Slide 4: Financial Highlights Q2 & H1 FY27
FINANCIAL HIGHLIGHTS Q2 & H1 FY27
Slide 5: Key Highlights of the Quarter
Key Highlights of the Quarter Q2 FY27 reflected resilient execution and steady progress on our strategic priorities. On a consolidated basis, Total Revenue grew 36% year-on-year to ₹472 crore, EBITDA rose 58% to ₹106 crore with a margin of 22%, and PAT increased 82% to ₹67 crore. For H1 FY27, consol
Slide 6: Financial highlights – Q2 FY27
Financial highlights – Q2 FY27 STANDALONE CONSOLIDATED Total Revenue (INR Cr) EBITDA (INR Cr) Total Revenue (INR Cr) EBITDA (INR Cr) 110 461 472 429 434 103 121 348 106 316 57 67 Q2 FY26 Q1FY27 Q2 FY27 Q2FY26 Q1FY27 Q2FY27 Q2FY26 Q1FY27 Q2FY27 Q2FY26 Q1FY27 Q2FY27 PAT (INR Cr) EBITDA & PAT MARGIN (%
Slide 7: Financial highlights – H1 FY27
Financial highlights – H1 FY27 STANDALONE CONSOLIDATED Total Revenue (INR Cr) EBITDA (INR Cr) Total Revenue (INR Cr) EBITDA (INR Cr) 933 227 863 213 715 643 121 131 H1 FY26 H1 FY27 H1 FY26 H1 FY27 H1 FY26 H1 FY27 H1 FY26 H1 FY27 PAT (INR Cr) EBITDA & PAT MARGIN (%) PAT (INR Cr) EBITDA & PAT MARGIN (
Slide 8: Standalone Statement of Profit & Loss
Standalone Statement of Profit & Loss Particulars (Rs.Crs.) Q2FY27 Q2FY26 Y-o-Y Q1FY27 Q-o-Q H1 FY27 H1 FY26 Total Revenue 434 316 37.33% 429 1.24% 863 643 Total Raw Material 239 177 237 476 357 Employee Expenses 24 18 24 48 37 Other Expenses 68 65 58 126 128 EBITDA 103 57 81.39% 110 -5.71% 213 121
Slide 9: Consolidated Statement of Profit & Loss
Consolidated Statement of Profit & Loss Particulars (Rs.Crs.) Q2FY27 Q2FY26 Y-o-Y Q1FY27 Q-o-Q H1 FY27 H1 FY26 Total Revenue 472 348 35.78% 461 2.28% 933 715 Total Raw Material 265 185 253 518 397 Employee Expenses 26 19 26 52 40 Other Expenses 75 76 61 136 147 EBITDA 106 67 58.46% 121 -12.72% 227 1
Slide 10: Consolidated Balance Sheet Statement
Consolidated Balance Sheet Statement ASSETS (Rs. Crs.) Sep-26 Mar-26 EQUITY AND LIABILITIES (Rs. Crs.) Sep-26 Mar-26 (1) NON-CURRENT ASSETS EQUITY (a) Property, plant & equipment 1,160 1,035 (a) Equity Share capital 6 6 (b) Other equity 2,077 1,970 (b) Capital work-in-progress 513 512 Attributable t
Slide 11: Consolidated Cash Flow Statement
Consolidated Cash Flow Statement Cash Flow Statement for half year ended (in Rs. Crore) Sep-26 Sep-25 Profit before Tax 196 101 Adjustment for Non-Operating Items 28 22 Operating Profit before Working Capital Changes 224 122 Changes in Working Capital -143 -85 Cash Generated from Operations 80 38 Le
Slide 12: Company Overview
af AMINES LIMITED COMPANY OVERVIEW
Slide 13: At a Glance
At a Glance One of India’s Largest Aliphatic amines 35+ India’s First years of WE BUILT INDIA’s 1st Commercial DME manufacturers manufacturing expertise INDIGENOUS TECHNOLOGY Manufacturer FOR MANUFACTURING Core ALIPHATIC AMINES processes 4,02,600+ Developed MTPA Installed through Capacity Driven by
Slide 14: Corporate Structure
Corporate Structure 4 Manufacturing Locations 2 Speciality Chemical Units (BSCL) Operations across Maharashtra & Telangana Strong multi-location Focus on High- Value Strategically located for scale manufacturing base Speciality Chemicals and efficiency Balaji Amines Ltd BALAJI AMINES BALAJI SPECIALI
Slide 15: Manufacturing Locations – Built for Scale
Manufacturing Locations – Built for Scale BALAJI AMINES Unit I – Solapur Unit II – Telangana Unit III – Solapur Unit IV – Solapur Certifications: Key Products: Key Products: • ISO 9001:2015 Key Products: Key Products: • Ethyl amines Quality Management Systems • Dimethyl Formamide • Methylamines • Di
Slide 16: Executing the Next Growth Phase
Executing the Next Growth Phase Commissioning key projects while advancing the next phase of speciality chemicals expansion. DME Successfully Commissioned ACN Commercialized | NMM Under R&D Mechanism (Q1 FY27) Execution STATUS: ACN (OPERATIONAL) STATUS: OPERATIONAL IN-HOUSE R&D PROGRAMME NMM (UNDER
Slide 17: BSCL – Building Future Capabilities
BSCL – Building Future Capabilities Driving import substitution through phased commissioning of high-value speciality chemical platforms BSCL Unit II – Phase I Progress BSCL Unit I – EDA Derivatives Platform STATUS: UNDER EXECUTION STATUS: UNDER EXECUTION • Greenfield project comprising HCN, Sodium
Slide 18: Positioned for Sustainable Growth
Positioned for Sustainable Growth Capex-to-Cashflow Unique Import-Substitution Structural Margin Growth Without Leverage Inflection Franchise Expansion • ₹1000 Cr+ expansion cycle • Only Indian producer of • Standalone business remains • Indigenous technology with nearing completion on Electronic Gr
Slide 19: BSCL – Scaling Speciality Chemicals
BSCL – Scaling Speciality Chemicals Balaji Speciality Chemicals Existing Licensed Proposed Capacity Total Capacity after Product Application Areas Capacity (TPA) (TPA) Expansions (TPA) Ethylenediamine 37,350 - 37,350 Pharma, Fungicides, Pesticides, Polymers and Coatings Piperazine 4,050 3,300 7,350
Slide 20: Manufacturing Capacity to Capture Future Demand
Manufacturing Capacity to Capture Future Demand Balaji Amines Existing Licensed Proposed Capacity Total Capacity after Product Application Areas Capacity (TPA) (TPA) Expansions (TPA) Methyl Amine 88,000 - 88,000 Pharma, Agro, Dye & Rubber Ethyl Amine 22,500 - 22,500 Pharma, Agro, Dye & Rubber DMAHCL
Slide 21: A Diversified Product Portfolio
A Diversified Product Portfolio Amines Amine Derivatives Speciality & Other Chemicals • The foundation of Balaji Amines' integrated • Value-added products that expand the • A high-value portfolio serving advanced value chain, supplying essential building Company's presence across pharmaceutical, app
Slide 22: Integrated Across the Value Chain
Integrated Across the Value Chain Feedstock Core Amines Amine Speciality End Markets Methanol Methylamine Derivatives Chemicals Pharma Morpholine Ethanol Ethylamine DMAHCL DME, DMF Agrochemicals EV NMP, NEP , GBL Ammonia, etc. Isopropylamine DMAC ACN Batteries Industrial DMU 2P , PVPK N Butylamine D
Slide 23: About Balaji Speciality Chemicals (BSCL)
About Balaji Speciality Chemicals (BSCL) Strategic Growth Platform Balaji Speciality Chemicals Limited (BSCL), a 55% subsidiary of Balaji Amines Limited, is our strategic platform for high-value speciality chemicals. Located in Solapur, Maharashtra, BSCL commenced commercial operations in 2019 and i
Slide 24: Trusted by Industry Leaders Across the Globe
Trusted by Industry Leaders Across the Globe Amines Amine Derivatives Speciality & Other Chemicals 23
Slide 25: Serving Diverse End Markets
Serving Diverse End Markets Industry Wise – Revenue Breakup 3% 6% 28% 63% Pharma Agro Oil & Gas Others 24
Slide 26: Expanding Global Footprints
Expanding Global Footprints OUR EXPORT PRESENCE Country Delivering our products to UK China 50+ countries across the world US Japan Argentina Turkey Canada Finland Indonesia Israel Switzerland India Sri Lanka Pakistan Russia Bangladesh Malaysia Oman Singapore Germany Bahrain Italy Jordan Egypt Guate
Slide 27: Hotel Balaji Sarovar
af AMINES LIMITED HOTEL BALAJI SAROVAR
Slide 28: About Balaji Sarovar Premiere Hotel
About Balaji Sarovar Premiere Hotel • Commenced Operations in October 2013 Hotel Balaji Sarovar Premier is the only 5 star hotel in Solapur • Invested Rs. 110 crore in the Hotel Project via mix of Debt and Equity • Tied up with Sarovar Group for the Management of the Hotel on Management Fee + Revenu
Slide 29: Balaji Sarovar Premiere – Q2 & H1 FY27 Operating Matrix
Balaji Sarovar Premiere – Q2 & H1 FY27 Operating Matrix Renowned Five Star Hotel In the City of Solapur 129 Rooms Constitutes Rs. 717 Lakhs 1.52% of Total Revenue Revenue from Hotel Division Rs. 4922 ADR 67% Rs. 3288 Occupancy Rate RevPAR ADR: Average Daily Rate 28 RevPAR: Revenue per Available Room
Slide 30: Historical Performance
af AMINES LIMITED HISTORICAL PERFORMANCE
Slide 31: Consolidated Performance Highlights
Consolidated Performance Highlights Revenue (Rs. Crs) EBITDA (Rs. Crs.) PAT (Rs. Crs.) 1671 353 232 294 265 159 169 1454 1430 2024 2025 2026 2024 2025 2026 2024 2025 2026 EBITDA Margin (%) PAT Margin (%) ROE (%) 14 13.5 21 11.64 11.1 20.24 9.17 8.6 18.5 2024 2025 2026 2024 2025 2026 2024 2025 2026 3
Slide 32: Strong Core ROCE Profile
Strong Core ROCE Profile Particulars (Rs. Crs.) FY26 FY25 Consolidated Debt 133 11 Quarter and half year ended September 2026: Consolidated Networth 2152 2018 Total Capital Employed 2285 2029 The capital work-in-progress across various units, totalling to Rs. 78.54 crore, pertains mainly to N-Methyl
Slide 33: Consistent Dividend Payout
Consistent Dividend Payout 550% 550% 550% 500% 300% 200% FY21 FY22 FY23 FY24 FY25 FY26 Particulars (Rs. per share) FY21 FY22 FY23 FY24 FY25 FY26 Consolidated Book Value 281 406 524 584 623 664 Consolidated EPS 74 114 100 63 49 52 Dividend 4.00 6.00 10.00 11.00 11.00 11.00 32
Slide 34: Leadership & Responsibility
LEADERSHIP & RESPONSIBILITY
Slide 35: Highly Experienced Management Team
Highly Experienced Management Team MR. A. PRATHAP REDDY MR. N. RAJESHWAR REDDY Executive Chairman Whole Time Director • Civil Engineer by Education. Incorporated BAL in 1988 • Commerce Graduate having over 48 years of experience • BAL's continuing success is a testimony to his across industries entr
Slide 36: Awards & Certificates – A Testimony of our capabilities
Awards & Certificates – A Testimony of our capabilities ISO Certificate Three Star Export House ISO Certificate BEST CEO (CHEMICAL INDUSTRY) AWARD TO SHRI ANDE PRATHAP REDDY BY BUSINESS TODAY GROUP ISO 9001 : 2015 Certificate Certificate of Merit - CHEMEXCIL First Award - CHEMEXCIL WHO GMP Certifica
Slide 37: Awards & Recognition - A Testimony of our capabilities
Awards & Recognition - A Testimony of our capabilities Balaji Amines Limited has been awarded as Sustainability Balaji Amines Limited has received the Best Project Award in Balaji Sarovar Premiere, has been honoured with the Food Leader of the Year in Chemicals at FICCI Chemicals and the area of Hea
Slide 38: ESG & CSR Initiatives
ESG & CSR Initiatives Constructed Classroom at ZPHS Chengal School, Mandal Construction of Toilet Block at Indira Kale Prashala, Distributed Sanitary Napkin Incinerator and Vending Machine Bhimgal, Nizamabad, dt. 04.01.2025 Jalkotwadi, dt. 25.03.2025 at Vishwabhushan Vidyalay, Solapur dt.30.09.2024
Slide 39: Thank You
COMPANY : Balaji Amines Limited CIN-L24132MH1988PLC049387 Investor Relations Team Email- cs@balajiamines.com cs@balajiamines.com www.balajiamines.com www.balajiamines.com INVESTOR RELATIONS ADVISORS : MUFG Intime India Private Limited A part of MUFG Corporate Markets, a division of MUFG Pension & Ma